Quadrivalent, inactivated influenza vaccine (IIV4)

Developed for: influenza
Investigated by: National Institute of Allergy and Infectious Diseases (NIAID) · Stanford University

today NCT01827462 · Ph 4

20082009201020112012201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 4	NCT01827462	Oct 2007 → Dec 2015	influenza	Stanford University	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Quadrivalent, inactivated influenza vaccine (IIV4)	ClinicalTrials.gov intervention name — accepted as the source's own label NCT01827462 ↗
Modality	Vaccine	“Quadrivalent, inactivated influenza vaccine (IIV4) was given.” NCT01827462 ↗